Ticker Details
Acumen Pharmaceuticals, Inc.
IPO Date:	July 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$228.52M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 4.29%
Avg Daily Range (30 D):	$0.11 | 4.34%
Avg Daily Range (90 D):	$0.09 | 3.79%

Institutional Daily Volume
Avg Daily Volume:	.37M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.33M

Trade Size
Avg Trade Size (Sh.):	121
Avg Trade Size (Sh.) (30 D):	97
Avg Trade Size (Sh.) (90 D):	98

Institutional Trades
Total Institutional Trades:	64
Avg Institutional Trade:	$2.18M
Avg Institutional Trade (30 D):	$5.14M
Avg Institutional Trade (90 D):	$2.9M
Avg Institutional Trade Volume:	.44M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.35M
Avg Closing Trade (30 D):	$9.68M
Avg Closing Trade (90 D):	$3.66M
Avg Closing Volume:	738.01K

News

May 12, 2026 @ 11:00 AM Acumen Pharmaceuticals Reports First Quarter 2026 ... Source: Acumen Pharmaceuticals, Inc.

May 7, 2026 @ 8:00 PM Acumen Pharmaceuticals to Participate in the Bank ... Source: Na

May 5, 2026 @ 8:00 PM Acumen Pharmaceuticals to Report First Quarter Fin... Source: Na

Mar 19, 2026 @ 8:00 PM Acumen Pharmaceuticals to Report Fourth Quarter an... Source: Na

Mar 10, 2026 @ 8:00 PM Acumen Pharmaceuticals to Participate in the Stife... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.45	$-.33	$-.41
Diluted EPS	$-.45	$-.33	$-.41
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-32.72M	$-20.74M	$-25.14M
Operating Income / Loss	$-32.56M	$-21.15M	$-25.2M
Cost of Revenue
Net Cash Flow	$7.65M	$-2.19M	$7.16M
PE Ratio